Search Within

Solid Tumor Oncology Division

  1. "Clifford Hudis"
Formats
  1. Journal Article (483)
  2. Meeting Abstract (393)
  3. Book Section (15)
  4. Conference Paper (10)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Breast Medicine Service (905)
  2. Department of Medicine (905)
  3. Survivorship Research (905)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (318)
  5. Epidemiology and Biostatistics (242)
  6. Biostatistics Service (221)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (293)
  3. Sujata Patil (141)
  4. Andrew Seidman (116)
  5. Chau Dang (111)
  6. Maura Dickler (102)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (246)
  2. Cancer Research (108)
  3. Breast Cancer Research and Treatment (77)
  4. Clinical Cancer Research (33)
  5. Cancer (30)
  6. Annals of Oncology (29)

More Publications

Publishers
  1. American Society of Clinical Oncology (249)
  2. American Association for Cancer Research (163)
  3. Springer (100)
  4. Elsevier Inc. (84)
  5. Oxford University Press (55)
  6. Wiley Blackwell (45)

More Publishers

Results (905)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Uniformly positive (> 80%) HER2 expression maximizes sensitivity and specificity for prediction of response to trastuzumab in CALGB 9840
    Meeting Abstract

    Rimm, D. L.; Broadwater, G.; Friedman, P.; Berry, D.; Seidman, A.; Hudis, C.; Winer, E.; Harris, L.; Thor, A.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • PIK3CA and AKT1 mutations are independent in invasive breast cancer
    Meeting Abstract

    Moynahan, M. E.; Heguy, A.; Drobnjak, M.; Traina, T.; Howard, J.; Patil, S.; Gerald, W.; Solit, D.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: No evidence of short-term changes in left ventricular ejection fraction
    Meeting Abstract

    Morris, P. G.; Dickler, M.; Mcarthur, H.; Traina, T.; Godfrey, L.; Steingart, R.; Rugo, H.; Lin, N.; Moy, B.; Come, S.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC)
    Meeting Abstract

    Mcarthur, H. L.; Lynch, C.; Morris, P.; Larson, S.; Grabski, K.; Howard, J.; Patil, S.; Hudis, C. A.; Dickler, M. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • High resolution representational oligonucleotide microarray analysis (ROMA) suggests that TOPO2 and HER2 co-amplification is uncommon in human breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Tan, L. K.; Patil, S.; Wigler, M.; Hudis, C. A.; Hicks, J.; Norton, L.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Clinical utility and future of genetic profiles for breast cancer
    Journal Article

    Hudis, C.
    Breast Cancer Research (2009)

    Fulltext@MSK | Save
  • TOPO2A and HER2 co-amplification is uncommon by high resolution representational oligonucleotide microarray analysis (ROMA) in human breast cancer
    Meeting Abstract

    Hicks, J.; Mcarthur, H.; Tan, L. K.; Patil, S.; Wigler, M.; Hudis, C.; Norton, L.
    Annals of Oncology (2009)

    Fulltext@MSK | Save